tiprankstipranks
Advertisement
Advertisement

SEPN Stock Latest News

Septerna price target raised to $38 from $34 at JPMorgan
The FlySepterna price target raised to $38 from $34 at JPMorgan
9d ago
SEPN
Septerna, Inc. (SEPN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Septerna, Inc. (SEPN) Q4 Earnings Cheat Sheet
10d ago
SEPN
Septerna price target raised to $35 from $34 at Truist
PremiumThe Fly
Septerna price target raised to $35 from $34 at Truist
22d ago
SEPN
Septerna files automatic mixed securities shelf
PremiumThe Fly
Septerna files automatic mixed securities shelf
23d ago
SEPN
Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating
PremiumRatings
Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating
24d ago
SEPN
Septerna reports Q4 EPS (24c), consensus (22c)
PremiumThe FlySepterna reports Q4 EPS (24c), consensus (22c)
24d ago
SEPN
Septerna (SEPN): Early Proof-of-Concept for SEP-631 in Mast Cell–Driven Disease Supports Long-Term Growth Potential
Premium
Ratings
Septerna (SEPN): Early Proof-of-Concept for SEP-631 in Mast Cell–Driven Disease Supports Long-Term Growth Potential
1M ago
SEPN
Septerna price target raised to $40 from $35 at H.C. Wainwright
Premium
The Fly
Septerna price target raised to $40 from $35 at H.C. Wainwright
1M ago
SEPN
Septerna Advances SEP-631 After Positive Phase 1 Results
PremiumCompany Announcements
Septerna Advances SEP-631 After Positive Phase 1 Results
1M ago
8K
SEPN
Septerna announces results from Phase 1 trial of SEP-631
PremiumThe Fly
Septerna announces results from Phase 1 trial of SEP-631
1M ago
SEPN
Septerna: Advancing GPCR Pipeline and De-Risked Valuation Support Upgraded Buy Rating and $35 Target
PremiumRatings
Septerna: Advancing GPCR Pipeline and De-Risked Valuation Support Upgraded Buy Rating and $35 Target
2M ago
SEPN
Septerna price target raised to $35 from $30 at H.C. Wainwright
PremiumThe Fly
Septerna price target raised to $35 from $30 at H.C. Wainwright
2M ago
SEPN
Septerna to Present GPCR Pipeline Updates at JPM Conference
PremiumCompany AnnouncementsSepterna to Present GPCR Pipeline Updates at JPM Conference
3M ago
8K
SEPN
Septerna Appoints Mark Wilson as Chief Legal Officer
Premium
Company Announcements
Septerna Appoints Mark Wilson as Chief Legal Officer
3M ago
8K
SEPN
Septerna appoints Mark Wilson as chief legal officer
Premium
The Fly
Septerna appoints Mark Wilson as chief legal officer
3M ago
NKTR
SEPN
Coty downgraded, Spruce Biosciences initiated: Wall Street’s top analyst calls
PremiumThe Fly
Coty downgraded, Spruce Biosciences initiated: Wall Street’s top analyst calls
3M ago
BC
AME
Septerna initiated with a Buy at JonesResearch
PremiumThe Fly
Septerna initiated with a Buy at JonesResearch
3M ago
SEPN
Septerna initiated with a Strong Buy at Raymond James
PremiumThe Fly
Septerna initiated with a Strong Buy at Raymond James
3M ago
SEPN
Septerna initiated with a Buy at Truist
PremiumThe Fly
Septerna initiated with a Buy at Truist
4M ago
SEPN
Septerna price target raised to $34 from $28 at JPMorgan
PremiumThe FlySepterna price target raised to $34 from $28 at JPMorgan
5M ago
SEPN
SEPN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SEPN Upcoming Earnings Report: What to Expect?
5M ago
SEPN
Wells upgrades Septerna to Overweight on 2026 share catalysts
Premium
The Fly
Wells upgrades Septerna to Overweight on 2026 share catalysts
5M ago
SEPN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >